213 results about "Glucose lowering" patented technology

Compositions and methods for administering ketone bodies to a subject include beta-hydroxybutyrate complexed with or coupled to at least one amino acid. The compositions and methods cause one or more of: weight loss, weight maintenance, reduced blood glucose level, maintenance of blood glucose level, increased muscle and physical performance, enhanced metabolic and cellular repair, improved detoxification and gut health, targeted bioavailability, sustained release and controlled absorption, increased metabolic efficiency, enhanced cellular uptake, minimized side effects, multifunctional therapeutics, improved focus, improved energy, improved cognitive function, improved mental acuity, treatment of traumatic brain injury, treatment of diabetes, treatment of neurological disorder, treatment of cancer, treatment of inflammatory condition, appetite suppression, anti-aging effects, anti-glycation effects, treatment of epilepsy, treatment of depression, improved performance, improved muscle mass, improved motor function, increased strength, increased metabolism, increased fat loss, increased fat oxidation, improved body composition, and improved mood.

The embodiment of the invention discloses a blood glucose index evaluation method, electronic equipment and a storage medium, and the method comprises the steps: obtaining the corresponding heart rate data of a target user in an evaluation time period, carrying out the feature extraction processing of the heart rate data, obtaining the corresponding target heart rate feature of the target user in the evaluation time period, and obtaining the target heart rate feature of the target user in the evaluation time period; inputting the target heart rate feature and a target calibration parameter corresponding to the target user into a blood glucose evaluation model, and predicting blood glucose control index data corresponding to the target user in the evaluation time period through the blood glucose evaluation model. The target heart rate features and the target calibration parameters are used as input of a blood glucose evaluation model, and the blood glucose management and control index data of the target user in the evaluation time period are predicted through the blood glucose evaluation model, so that it is ensured that the obtained heart rate data corresponding to the target user in the evaluation time period are utilized; and the accuracy of the blood glucose management and control index data corresponding to the target user in the evaluation time period is determined, and meanwhile, the cost of blood glucose monitoring is greatly reduced.

The invention provides an application of cichorium glandulosum polysaccharide in preparation, basic characterization and type 2 diabetes mellitus relieving medicines, and belongs to the technical field of medicines. Animal experiment results show that after the cichorium glandulosum polysaccharide is applied to type 2 diabetic mice, serum biochemical indexes can be adjusted, the blood sugar level can be reduced, organ injuries can be protected or repaired, and PI3K / AKT / mTOR signal channel related protein expression in the main glycometabolism target organ liver can be adjusted. Therefore, the prepared cichorium glandulosum polysaccharide can be used as a medicine for relieving type 2 diabetes mellitus.

The invention discloses a cane molasses extract with a blood sugar reducing effect as well as a preparation method and application thereof, and belongs to the field of functional foods. According to the invention, cane molasses is subjected to dissolution, centrifugation, ultrafiltration impurity removal, desalination and nanofiltration concentration, and is mixed with calcium chloride, so that the cane molasses extract with the effect of reducing blood sugar is prepared. Experimental results prove that the cane molasses extract prepared by the invention has the characteristics of low glycemic index (GI), carbohydrate digestive enzyme inhibition, high temperature resistance, long-term storage resistance and the like, can also effectively repair pancreas and liver injury and regulate intestinal flora, and has a comprehensive hypoglycemic effect. The food with low glycemic index is prepared on the basis of the high sucrose carrier for the first time, and the food has sweet taste and the function of reducing blood sugar. The invention provides a new raw material scheme for the preparation of dietary supplement food and hypoglycemic drugs for hyperglycemia people, and has prominent practical application value and wide application prospect.

The invention relates to the technical field of biological medicines, in particular to application of Amomum villosum Lour. In preparation of products for preventing and / or improving symptoms related to obesity and glucose and lipid metabolism disorder. The symptoms comprise hyperglycemia level, cardiovascular and cerebrovascular diseases, cognitive impairment and the like. The result shows that the fructus amomi can effectively reduce the blood sugar level, obviously inhibit the rise of low-density lipoprotein, improve the cognitive function and regulate the lipid metabolism balance. Based on good glycolipid metabolism regulation activity, fructus amomi can be used for improving hyperglycemia, cardiovascular and cerebrovascular diseases, related cognitive function decline and other symptoms caused by abnormal glycolipid metabolism.

The present application relates to a kind of pharmaceutical composition for treating type 2 diabetes and its application.The pharmaceutical composition includes icariin, hydroxymethyl coumarin and cinnamaldehyde, by three-component synergistic effect, simultaneously act on insulin resistance, pancreatic beta cell apoptosis and systemic metabolic inflammation three type 2 diabetes core pathological links, auxiliary reduce serum lipid level, and reduce drug-related liver injury risk, good safety.Animal experiment results show that three-drug combination group can effectively reduce blood sugar (decrease about 50%), significantly improve islet structure atrophy, restore hepatocyte index arrangement, reduce glomerular hypertrophy, significantly reduce serum TG and CHOL level (P<0.05) and inflammatory factor IL-6 and TNF-alpha level (P<0.05), and avoid the hepatotoxicity risk (ALT / AST restores to close to normal level) of hydroxymethyl coumarin.The present application is composed of three kinds of natural monomers with clear structure, and has clear components and controllable quality, which provides a more optimal comprehensive treatment strategy for the treatment of type 2 diabetes and its complications.

The invention belongs to the technical field of medicinal chemistry, and relates to 3-amino-4-(2, 4, 5-trifluorophenyl) bornyl butyrate as well as a preparation method and application thereof. The 3-amino-4-(2, 4, 5-trifluorophenyl) bornyl butyrate has the following structure: the 3-amino-4-(2, 4, 5-trifluorophenyl) bornyl butyrate provided by the invention has an excellent hypoglycemic effect, has a low toxic effect on AC16 cells, and provides a treatment choice with better efficiency and higher safety for diabetics.

The invention discloses nutrition-balanced flour assisting in pancreas islet repair as well as a preparation method and application of the nutrition-balanced flour. The nutrition-balanced flour is prepared from the following raw materials in parts by mass: 40-60 parts of whole grains, 10-15 parts of beans, 5-15 parts of vital gluten, 7-10 parts of potatoes, 7-10 parts of vegetables, 5-8 parts of bacteria and algae, 5-8 parts of nut seeds, 3-5 parts of medicinal and edible food and 3-5 parts of beer yeast. The invention provides more comprehensive nutrition powder containing whole grains, beans, potatoes, nuts and the like, and further comprises common food with the effect of reducing blood sugar and medicinal and edible food which has the effect of reducing blood sugar and can prevent diabetic complications, and the nutrition flour has the following functions: balanced nutrition is provided for the body; blood sugar reduction is assisted; the islet cells are assisted to repair; and diabetic complications are prevented. The invention relates to an application of nutrition-balanced flour assisting in pancreas islet repair. The flour is used for making steamed buns, dumplings, steamed stuffed buns, wontons, noodles, cakes, biscuits or other flour products.

The application discloses a glucagon peptide-1 and glucagon receptor dual-agonistic polypeptide and application thereof, and the polypeptide structure is shown in the following general formula (I). The dual-agonistic polypeptide has dual-agonistic activity on human GLP-1 and glucagon receptors. The GLP-1 / glucagon receptor dual-agonistic polypeptide can effectively reduce blood sugar and weight, and has obvious lipid-regulating effect. The GLP-1 / glucagon receptor dual-agonistic polypeptide is stable in vivo, and is suitable to be used as an active component of drugs for diabetes, obesity, hyperlipidemia and the like.

The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.

The invention belongs to the field of new application of medicines, and particularly relates to application of triptolide in preparation of medicines for treating diabetic vascular obstruction complications. Diabetes vascular obstruction is a common serious complication of diabetes and can cause various tissue injuries such as cardiovascular diseases, nephropathy and retinopathy. Experiments prove that the triptolide can remarkably improve the problems of blood vessel blockage, blood flow slowing, abnormal neovascularization and the like caused in a high-glucose environment, and meanwhile, the expression of blood glucose related indexes (such as Glucose and HbA1c) and inflammatory factors (such as TNF-alpha and IL-1beta) is reduced. In addition, triptolide can also protect pancreas from high glucose damage and improve functions of pancreatic beta cells. According to the invention, the clinical application range of the triptolide is expanded, and a new candidate substance is provided for drug treatment of diabetic vascular complications.

The invention belongs to the technical field of medicines, and relates to an application of a pharmaceutical composition in preparation of medicines for preventing and / or treating type II diabetes mellitus. The invention provides an application of a pharmaceutical composition in preparation of a medicine for preventing and / or treating type II diabetes mellitus. The pharmaceutical composition comprises the following components: ginsenoside Rk1, ginsenoside Rg5, ginsenoside Rg3, ginsenoside Rh4, ginsenoside Rk3, a ginseng ethanol-water extract and a pharmaceutically acceptable carrier. The pharmaceutical composition component provided by the invention can effectively reduce blood sugar and / or reduce the glycosylated hemoglobin level, and prevent and / or treat type II diabetes mellitus.

The present invention relates to a Korean microbiome-derived Clostridium butyricum strain having anti-obesity efficacy and a use thereof. The strain has an excellent effect of reducing the body weight and adipose tissue weight of experimental animals compared to a control group (strain-untreated) under high-fat diet conditions, has an excellent effect of reducing the content of total cholesterol, triglycerides, low-density lipoprotein (LDL), leptin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in serum, and has an excellent effect of reducing blood glucose and increasing the content of glucagon-like peptide-1 (GLP-1) in an oral glucose load test, and is thus expected to be effectively used as an ingredient in a composition for preventing, alleviating, or treating obesity and metabolic diseases caused by obesity.

The invention discloses polygonatum cyrtonema polysaccharide as well as a preparation method and application thereof, and relates to the technical field of plant polysaccharide extraction. The invention relates to the technical field of biological medicine, in particular to polygonatum cyrtonema polysaccharide as well as a preparation method and application thereof. The polygonatum cyrtonema polysaccharide is composed of fructose and glucose according to the molar ratio of 27.5: 1, the main chain of the polygonatum cyrtonema polysaccharide is of a 1-beta-D-Fruf-(2-) structure, and the side chain of the polygonatum cyrtonema polysaccharide comprises-> 6-beta-D-Fruf-(2-) and-> 1, 6-beta-D-Fruf-(2-). The polygonatum cyrtonema polysaccharide provided by the invention has the activity of reducing blood sugar, reducing blood fat and relieving insulin resistance, and has a wide application prospect in the aspect of developing functional foods or medicines for adjuvant therapy of diabetes mellitus.

The invention discloses a traditional Chinese medicine preparation for treating hand and foot numbness caused by diabetes and a preparation method and application thereof, and belongs to the field of traditional Chinese medicine preparations. The traditional Chinese medicine preparation is prepared by the following method: (1) uniformly mixing 15-21 parts by weight of aleppo avens, 27-33 parts by weight of potentilla fruticosa and 2-12 parts by weight of pseudo-ginseng, crushing, and sieving with a 50-mesh sieve to obtain powder; (2) adding the powder obtained in the step (1) into an ethanol aqueous solution with the concentration of 48-52v / v% for dipping and extracting under the conditions that the material-liquid ratio is (1: 8)-(1: 12), the extraction temperature is 40-60 DEG C and the extraction time is 2-4 hours to obtain an extracting solution; (3) filtering the extracting solution obtained in the step (2), and removing ethanol and water from the filtrate to obtain a crude extract; (4) adding petroleum ether into the crude extract obtained in the step (3) for extraction, and removing petroleum ether to obtain a refined product at the lower layer; and (5) taking the refined product in the step (4), and performing spray drying to obtain finished medicinal powder. The traditional Chinese medicine preparation disclosed by the invention can cure hand and foot numbness caused by diabetes mellitus by reducing blood sugar content, dredging blood vessels, strengthening qi and nourishing blood.

The present invention relates to an anti-diabetic effect of a Cucumis melo leaf extract, particularly an alcohol extract of Cucumis melo leaves. The Cucumis melo leaf extract of the present invention can provide an anti-diabetic effect through a blood glucose-lowering effect. In addition, the Cucumis melo leaf extract of the present invention has a high yield of about 21%, and thus can be high feasibility as an excellent anti-diabetic material.

The invention discloses a traditional Chinese medicine monomer composition derived from chrysanthemum plants and used for treating diabetic retinopathy as well as a preparation method and application of the traditional Chinese medicine monomer composition. The traditional Chinese medicine monomer composition prepared from the chrysanthemum plant as the raw material is high in safety, small in side effect and definite in component and is prepared according to a specific ratio, and pharmacodynamic experiments prove that compared with an ethanol extract, the traditional Chinese medicine monomer composition is more remarkable in curative effect on diabetic retinopathy, and the curative effect of the traditional Chinese medicine monomer composition on diabetic retinopathy is better than that of a traditional Chinese medicine composition on diabetic retinopathy. The composition can improve the pathological state of diabetic retinopathy from multiple targets and multiple ways, specifically can inhibit body mass increase caused by high glucose, reduce blood glucose level, improve retinal tissue structure damage, recover retinal tissue thickness, inhibit retinal cell apoptosis and inflammatory response, reduce the expression level of HIF-1alpha and VEGF protein in retinal tissue, and can be used for treating diabetic retinopathy. Scientific basis and technical support are provided for research and development of novel drugs for treating the diabetic retinopathy, and important clinical significance and market application prospects are achieved.

The invention provides emblic leafflower fruit polysaccharide with a weight losing effect and an efficient preparation method and application thereof, and belongs to the field of plant polysaccharide. The preparation method comprises the following steps: performing powdering, water extraction and concentration on a phyllanthus emblica raw material, adding an alcohol solvent for precipitation, and drying to obtain phyllanthus emblica crude polysaccharide; after the phyllanthus emblica crude polysaccharide is dissolved, impurities are removed through membrane filtration, protein substances are adsorbed through a reversed-phase chromatographic column, flow-through liquid and water leacheate are collected and combined, small-molecular-weight substances are removed through a membrane bag, intercepted liquid is collected and dried, and the phyllanthus emblica polysaccharide is obtained. The phyllanthus emblica polysaccharide has alpha-type and beta-type glycosidic bonds, and has linear polysaccharide chains and aggregates formed by a plurality of chains. The emblic leafflower fruit polysaccharide is used for preparing products for reducing fat and blood sugar, and can also be used for preparing medicines for preventing and treating abnormal glucose metabolism, abnormal lipid metabolism, related diseases, obesity and liver injury caused by obesity. The phyllanthus emblica polysaccharide extraction and purification preparation method is simple and efficient, and is convenient for industrial implementation.

Compositions are disclosed that include at least one protein disulfide isomerase or a biologically active fragment or variant thereof. Methods of producing and using the compositions are also disclosed. In particular (but not by way of limitation), methods are provided for reducing blood glucose, treating hyperglycemia, treating or reducing the occurrence of type 1 diabetes, treating or reducing the occurrence of type 2 diabetes, and / or treating or reducing the occurrence of type 3 diabetes (i.e., Alzheimer's Disease) by administering the composition that includes the at least one protein disulfide isomerase. The protein disulfide isomerase may be administered alone or may be administered simultaneously or sequentially with one or more additional active agents.

The application discloses a quinoa hexapeptide with a blood sugar lowering effect and application thereof, and belongs to the technical field of bioactive peptides. The amino acid sequence of the quinoa hexapeptide PGSPGR is Pro-Gly-Ser-Pro-Gly-Arg. The quinoa hexapeptide PGSPGR has alpha-glucosidase inhibitory activity and can effectively reduce blood sugar level, and therefore, can be applied to preparation of medicines or food for lowering blood sugar. The application further provides a polypeptide containing the peptide segment PGSPGR and a quinoa peptide rich in the polypeptide, and the polypeptide and the quinoa peptide are applied to preparation of medicines or food for lowering blood sugar, thereby providing a new scheme and theoretical basis for treatment of diabetes, and having good market prospect and application potential.

The present application relates to the field of microorganisms, in particular to a mucinophilic Akkermansia strain and application thereof, the mucinophilic Akkermansia has a preservation number of CCTCC NO: M 20241304.The mucinophilic Akkermansia AKK-86 of the present application has good effects of promoting iron absorption, improving iron metabolism, and relieving intestinal inflammation.In addition, the mucinophilic Akkermansia of the present application can also promote the production of GLP-1, and has potential application in reducing blood sugar and weight loss products.

Exemplary embodiments account for differing needs of a user over the menstrual cycle of the user to better control the blood glucose concentration of the user. The exemplary embodiments may be realized in control systems for medicament delivery devices that deliver medicaments, such as medicaments that regulate blood glucose concentration levels. Examples of such medicaments that regulate blood glucose concentration levels include insulin, glucagon, and glucagon peptide-1 (GLP-1) agonists. The exemplary embodiments are able to better tailor the dosages of the medicament delivered to the user with the medicament delivery device to reduce the risk of hyperglycemia and hypoglycemia and help reduce blood glucose concentration excursions.

Provided is a use of a G protein-coupled receptor kinase 2 (GRK2) degradation compound in lowering blood glucose, stimulating or increasing insulin secretion, or preventing or treating a disease or disorder related thereto. Specifically, provided is a use of a compound represented by Formula (1) that degrades G protein-coupled receptor kinase 2 (GRK2) or a pharmaceutically acceptable salt, an isomer, an isotope, a prodrug, a solvate, or a polymorph thereof or a pharmaceutical composition comprising the same in lowering blood glucose, stimulating or increasing insulin secretion, or preventing or treating a disease or disorder that is ameliorable by lowering blood glucose, for example a pre-diabetic condition, a diabetes, or a complication related to a pre-diabetic condition or a diabetes in a subject in need thereof.

The present invention relates to the technical field of microorganisms, in particular to a Lactobacillus acidophilus GOLDGUT-LA100 having functions of lipid lowering, blood glucose lowering and weight loss and application thereof. The Lactobacillus acidophilus GOLDGUT-LA100 provided by the present invention is preserved in China General Microbiological Culture Collection Center, with the preservation number of CGMCC No. 28398. The strain has strong acid resistance, can adapt to the digestive tract environment, and has high bile salt hydrolase activity. At the same time, in animal experiments, the strain significantly reduces blood glucose and serum cholesterol levels, reduces liver fat deposition, reduces adipose tissue inflammation, effectively reduces the weight, and has broad application prospects in the development of products for improving obesity, lowering lipid and lowering blood glucose.

The invention discloses a pancreas-eliminating traditional Chinese medicine preparation for treating diabetes mellitus, which is prepared from the following components in parts by weight: 8 to 20 parts of bitter gourd extract, 6 to 20 parts of rhizoma atractylodis, 8 to 20 parts of rhizoma atractylodis macrocephalae, 10 to 25 parts of poria cocos, 10 to 25 parts of ramuli euonymi and 10 to 25 parts of fried semen raphani. The traditional Chinese medicine can effectively reduce blood sugar and improve chronic complications caused by diabetes mellitus, and effective components in the medicinal materials have a synergistic effect, so that the effect of treating diabetes mellitus can be more comprehensively exerted; according to the method, effective components such as bitter gourd, ferulic acid and chlorophyll are extracted by using a supercritical fluid extraction technology, the extraction efficiency can be improved, the stability and biological activity of the active components can be maintained, and compared with a traditional decoction method, the effective components in the medicinal materials can be more efficiently extracted by using technologies such as ultrasonic-assisted extraction or hydrothermal extraction; the dissolution of harmful substances is reduced, and the safety and curative effect of the preparation are improved.

The present application relates to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition with hypoglycemic effect and a preparation method thereof.The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 15-23 parts of Astragalus membranaceus, 12-18 parts of Sambucus williamsii root, 10-15 parts of Fructus Corni, 5-8 parts of Artemisia argyi stem, 1-5 parts of Fructus Camptothecae, 1-5 parts of Rhamnus utilis, 3-8 parts of Pueraria lobata, 1-5 parts of Morus alba leaf, and 1-3 parts of Radix Glycyrrhizae.The components of the traditional Chinese medicine composition are compatible with each other according to a certain ratio, can tonify qi and raise yang, dredge Sanjiao, expel evil, promote blood circulation and unblock collaterals, jointly achieve the effects of tonifying qi and nourishing, promoting qi and relieving pain, and tonifying kidney and dredging collaterals, can reduce blood sugar content, protect the cardiovascular system, achieve the effects of preventing and treating diabetes, and have practicality and application value.

The invention relates to the technical field of insulin derivatives, in particular to a long-acting acylated insulin derivative and application thereof. The long-acting acylated insulin derivative is formed by acylating and connecting a fatty acid side chain and an insulin peptide chain, and the fatty acid side chain is acylated and connected with epsilon amino of amino acid K on the insulin peptide chain. The insulin derivative provided by the invention has excellent hypoglycemic ability, the action time is remarkably prolonged, the insulin derivative can be administrated once a week, the compliance and sugar control willingness of a patient can be remarkably improved, and the insulin derivative has a wide market prospect.

A Smad5 mutant and uses thereof in the prevention and treatment of diabetes. The amino acid sequence of the Smad5 mutant is as shown in SEQ NO ID:1. The invention further relates to a nucleic acid encoding the Smad5 mutant, a recombinant expression vector containing the nucleic acid, and a transformant. The uses also comprise uses of the nucleic acid, the recombinant expression vector containing the nucleic acid, and the transformant in the preparation of a medicament for preventing and / or treating diabetes. The Smad5 mutant can improve symptoms of type 1 and type 2 diabetes in vivo, and, compared with conventional oral hypoglycemic drugs, has no toxic or side effects and does not cause damage to the liver or kidneys of patients. In addition, the invention relates to a reagent for regulating acid-base balance, comprising alkaline drinking water containing baking soda; the reagent can lower blood glucose, alleviate diabetic symptoms, and is more economical and convenient for patients to use.

The invention belongs to the technical field of foods, and particularly relates to a high-biological-activity muscle-building formula food for middle-aged and elderly people and a preparation method thereof. According to the high-biological-activity muscle-building formula food for the middle-aged and elderly people, the prepared mulberry leaf extract is added, the raw material raw milk is subjected to multi-stage membrane filtration to enrich beta-lactoglobulin, other auxiliary materials are adopted, muscle attenuation can be delayed, blood sugar can be remarkably reduced, sufficient nutrition support can be provided for the middle-aged and elderly people, and the high-biological-activity muscle-building formula food is suitable for the middle-aged and elderly people. The content of beta-lactoglobulin in the formula is not less than 3%, so that muscle health can be effectively improved, the immune barrier is improved, and functional decline is delayed.

The present invention belongs to the technical field of diabetic nephropathy drugs, and particularly relates to a traditional Chinese medicine composition for treating early diabetic nephropathy and a preparation method thereof. The traditional Chinese medicine composition comprises the following main components by weight: 20-40 parts of astragalus, 10-20 parts of pseudoginseng, 20-40 parts of raw rehmannia, 10-20 parts of cornus officinalis, 10-20 parts of winter mallow seeds, 10-20 parts of euryale ferox, 9-15 parts of morus alba bark, 10-20 parts of zedoaria, 3-6 parts of leeches, and 3-6 parts of scorpions. The traditional Chinese medicine composition combines kidney-tonifying and spleen-invigorating drugs with blood circulation-activating and collateral-dredging drugs, and is nutritious without being greasy, and attacks pathogens without damaging the body, thereby jointly achieving the functions of invigorating the spleen and replenishing qi, tonifying the kidney, activating blood circulation and dredging collaterals, and having significant therapeutic effects in lowering blood sugar and blood creatinine, improving symptoms of diabetic nephropathy, and improving the quality of life of patients.